Clinical Trials Browser

Completed × Graft vs Host Disease × Rituximab × Clear all

NCT02423915 2021-01-08

Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention

Phase 1 Completed

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma

NCT00785330 2020-01-13

Allo-hNHL (FluBuCy)

Phase 2 Completed

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

NCT02484053 2018-07-11

Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders

Phase EARLY_PHASE1 Completed

Graft vs Host Disease, Hematologic Diseases, Lymphoma

NCT00427557 2012-05-28

Cellular Therapy With Cord Blood Cells

Phase 2 Completed

31 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma